The ABL and JAK Tyrosine Kinase Pathways Are Co-Activated in BCR/ABL1 Positive Acute Lymphoblastic Leukemia

被引：0
|
作者：
Bhagavathi, S. [1 ]
Aviv, H. [1 ]
机构：
[1] Rutgers State Univ, New Brunswick, NJ USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2016年 / 18卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
H30
引用
收藏
页码：958 / 958
页数：1
相关论文
共 50 条
  • [1] The ABL and JAK Tyrosine Kinase Pathways May be Co-Activated in a Subset of BCR/ABL1 Positive Acute Lymphoid Leukemia
    Aviv, Hana
    Cancer Genetics, 2016, 209 (05) : 235 - 235
  • [2] New ABL1 Kinase Domain Mutations in BCR::ABL1-Positive Acute Lymphoblastic Leukemia
    Li, Zixuan
    Peng, Danyue
    Deng, Jun
    Xiong, Lv
    Yin, Ping
    Hu, Jing
    Qian, Chenjing
    Yao, Lan
    Yin, Hua
    Hong, Mei
    Wu, Qiuling
    CANCER MEDICINE, 2024, 13 (20):
  • [3] Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia
    Leoni, Veronica
    Biondi, Andrea
    HAEMATOLOGICA, 2015, 100 (03) : 295 - 299
  • [4] Detection of ABL1 kinase domain mutations in therapy-naive BCR-ABL1-positive acute lymphoblastic leukemia
    Baer, Constance
    Meggendorfer, Manja
    Haferlach, Claudia
    Kern, Wolfgang
    Haferlach, Torsten
    HAEMATOLOGICA, 2022, 107 (02) : 562 - 563
  • [5] BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia
    Rizzotto, Lara
    Saccenti, Elena
    Sofritti, Olga
    Daghia, Giulia
    Volta, Eleonora
    Caprini, Elisabetta
    Lupini, Laura
    Tammiso, Elisa
    Bardi, Antonella
    Lista, Enrico
    Ciccone, Maria
    Russo, Giandomenico
    Negrini, Massimo
    Cuneo, Antonio
    Rigolin, Gian Matteo
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2065 - 2067
  • [6] Distinct Pattern of ABL1 Genomic Breakpoints in Chronic Myeloid Leukemia and BCR::ABL1-Positive Acute Lymphoblastic Leukemia: Analysis of 884 Patients with Minor and Major BCR::ABL1 Fusion
    Hovorkova, Lenka
    Winkowska, Lucie
    Krotka, Justina
    Krumbholz, Manuela
    Meyer, Claus
    Sutton, Rosemary
    Henderson, Michelle
    Clappier, Emmanuelle
    Chiaretti, Sabina
    Sramkova, Lucie
    Stary, Jan
    Benesova, Adela
    Polakova, Katerina Machova
    Marschalek, Rolf
    Metzler, Markus
    Cazzaniga, Giovanni
    Cario, Gunnar
    Trka, Jan
    Zaliova, Marketa
    Zuna, Jan
    BLOOD, 2023, 142
  • [7] ABL1 Gene Deletion without BCR/ABL1 Rearrangement in B-Cell Acute Lymphoblastic Leukemia
    Yu, Mingwei
    Chang, Jason
    Gao, Wenli
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 : S6 - S7
  • [8] PATTERN OF CNS RELAPSE IN ACUTE LYMPHOBLASTIC LEUKEMIA BCR-ABL POSITIVE, THE IMPORTANCE OF CHARACTERIZATION OF ABL1 MUTATIONS IN CEREBROSPINAL FLUID
    Sanchez, R.
    Ayala, R.
    Alonso, R. A.
    Ribera, J.
    Garcia, O.
    Mercadal, S.
    Montesinos, P.
    Martino, R.
    Barba, P.
    Gonzalez-Campos, J.
    Barrios, M.
    Lavilla, E.
    Gil, C.
    Bernal, T.
    Escoda, L.
    Abella, E.
    Amigo, M. L.
    Moreno, M. J.
    Bravo, P.
    Guardia, R.
    Hernandez-Rivas, J. M.
    Garcia-Guinon, A.
    Piernas, S.
    Ribera, J. M.
    Martinez-Lopez, J.
    HAEMATOLOGICA, 2016, 101 : 354 - 354
  • [9] A new mechanism of resistance to ABL1 tyrosine kinase inhibitors in a BCR-ABL1-positive cell line
    Airiau, Kelly
    Turcq, Beatrice
    Mahon, Francois-Xavier
    Belloc, Francis
    LEUKEMIA RESEARCH, 2017, 61 : 44 - 52
  • [10] Emerging BCR/ABL1 Mutations Under Treatment with Tyrosine Kinase inhibitors in Paediatric Acute Lymphoblastic Leukaemia
    Molinos-Quintana, Agueda
    Aquino, Virginia
    Montero, Isabel
    Perez-de Soto, Concepcion
    Garcia-Lozano, Raul
    Antonio Perez-Simon, Jose
    Maria Perez-Hurtado, Jose
    ACTA HAEMATOLOGICA, 2015, 134 (02) : 71 - 75
12345